Bruker Corporation: Bruker Expects its FluoroType SARS-CoV-2 varID Q PCR Assay to Reliably Detect and Tentatively Differentiate Omicron (B.1.1.529) Variant

Includes robust dual-target SARS-CoV-2 detection and identification of 4 S-gene mutations Reliable detection and even tentative differentiation of Omicron variant expected Validated

Related Keywords

South Africa ,United States ,Philip Perry ,Hain Lifescience Gmb ,Bruker Corporation Nasdaq ,Business Wire ,Molecular Diagnostics ,Microbiology Diagnostics Business ,Hain Lifescience Gmbh ,Bruker Corporation ,Bruker Daltonics Microbiology Diagnostics ,Bruker ,Corporation ,Xpects ,Luorotype ,Cars ,Arid ,Essay ,Reliably ,Etect ,Tentatively ,Differentiate ,Micron ,Variant ,